Probiotics and prebiotics for gastrointestinal infections

There is growing interest in and knowledge about the potential health-promoting benefits of both probiotics and prebiotics. Multiple mechanisms of action for the beneficial effect of probiotics and prebiotics have been postulated, including prevention of pathogenic bacteria growth, production of ant...

Full description

Saved in:
Bibliographic Details
Published in:Current infectious disease reports 2006-03, Vol.8 (2), p.103-109
Main Authors: Novak, Joshua, Katz, Jeffry A
Format: Article
Language:English
Subjects:
Antimicrobial agents
Bacterial infections
Epidemiology
Gastrointestinal diseases
Health promotion
Infectious diseases
Medical treatment
Prevention
Probiotics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3
cites cdi_FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3
container_end_page 109
container_issue 2
container_start_page 103
container_title Current infectious disease reports
container_volume 8
creator Novak, Joshua
Katz, Jeffry A
description There is growing interest in and knowledge about the potential health-promoting benefits of both probiotics and prebiotics. Multiple mechanisms of action for the beneficial effect of probiotics and prebiotics have been postulated, including prevention of pathogenic bacteria growth, production of antimicrobial agents, stimulation of mucosal barrier function, and altering immunoregulation. Clinical trials support the efficacy of probiotics in the treatment of acute infectious diarrhea, the prevention of antibiotic associated diarrhea, and the prevention of recurrent Clostridium difficile infection. Although some data support the potential benefit of probiotic therapy in traveler's diarrhea, diverticular disease, and Helicobacter pylori, the strength of this evidence is limited. This paper will review the recent literature relevant to the mechanism of action and utility of probiotics and prebiotics in the treatment of gastrointestinal infections.
doi_str_mv 10.1007/s11908-006-0005-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67727635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67727635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMotlZ_gBdZPHhbnXxnj1L8goIe9ByySVZStpua7B7896a0IngY5oP3nRkehC4x3GIAeZcxbkDVAKIE8Lo5QnPMKaspZuJ4VxNaU8XkDJ3lvAYgxaVO0QwLThhnYo6atxTbEMdgc2UGV22T_227mKpPk8cUwzD6PIbB9FUYOm_HEId8jk4602d_ccgL9PH48L58rlevTy_L-1VtCcNjOQ8UW4MFI8Ctk85h7q1XUrHONYaBaX0LnYIydsqDI0pZTqUy0nMuDF2gm_3ebYpfU_lDb0K2vu_N4OOUtZCSSEF5EV7_E67jlMrTWRMgQgiGRRHhvcimmHPynd6msDHpW2PQO6h6D1UXqHoHVTfFc3VYPLUb7_4cB4r0B-AFcbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>202666416</pqid></control><display><type>article</type><title>Probiotics and prebiotics for gastrointestinal infections</title><source>Springer Link</source><creator>Novak, Joshua ; Katz, Jeffry A</creator><creatorcontrib>Novak, Joshua ; Katz, Jeffry A</creatorcontrib><description>There is growing interest in and knowledge about the potential health-promoting benefits of both probiotics and prebiotics. Multiple mechanisms of action for the beneficial effect of probiotics and prebiotics have been postulated, including prevention of pathogenic bacteria growth, production of antimicrobial agents, stimulation of mucosal barrier function, and altering immunoregulation. Clinical trials support the efficacy of probiotics in the treatment of acute infectious diarrhea, the prevention of antibiotic associated diarrhea, and the prevention of recurrent Clostridium difficile infection. Although some data support the potential benefit of probiotic therapy in traveler's diarrhea, diverticular disease, and Helicobacter pylori, the strength of this evidence is limited. This paper will review the recent literature relevant to the mechanism of action and utility of probiotics and prebiotics in the treatment of gastrointestinal infections.</description><identifier>ISSN: 1523-3847</identifier><identifier>EISSN: 1534-3146</identifier><identifier>DOI: 10.1007/s11908-006-0005-9</identifier><identifier>PMID: 16524546</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Antimicrobial agents ; Bacterial infections ; Epidemiology ; Gastrointestinal diseases ; Health promotion ; Infectious diseases ; Medical treatment ; Prevention ; Probiotics</subject><ispartof>Current infectious disease reports, 2006-03, Vol.8 (2), p.103-109</ispartof><rights>Current Science Inc. 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3</citedby><cites>FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16524546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Novak, Joshua</creatorcontrib><creatorcontrib>Katz, Jeffry A</creatorcontrib><title>Probiotics and prebiotics for gastrointestinal infections</title><title>Current infectious disease reports</title><addtitle>Curr Infect Dis Rep</addtitle><description>There is growing interest in and knowledge about the potential health-promoting benefits of both probiotics and prebiotics. Multiple mechanisms of action for the beneficial effect of probiotics and prebiotics have been postulated, including prevention of pathogenic bacteria growth, production of antimicrobial agents, stimulation of mucosal barrier function, and altering immunoregulation. Clinical trials support the efficacy of probiotics in the treatment of acute infectious diarrhea, the prevention of antibiotic associated diarrhea, and the prevention of recurrent Clostridium difficile infection. Although some data support the potential benefit of probiotic therapy in traveler's diarrhea, diverticular disease, and Helicobacter pylori, the strength of this evidence is limited. This paper will review the recent literature relevant to the mechanism of action and utility of probiotics and prebiotics in the treatment of gastrointestinal infections.</description><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Epidemiology</subject><subject>Gastrointestinal diseases</subject><subject>Health promotion</subject><subject>Infectious diseases</subject><subject>Medical treatment</subject><subject>Prevention</subject><subject>Probiotics</subject><issn>1523-3847</issn><issn>1534-3146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpdkE1LAzEQhoMotlZ_gBdZPHhbnXxnj1L8goIe9ByySVZStpua7B7896a0IngY5oP3nRkehC4x3GIAeZcxbkDVAKIE8Lo5QnPMKaspZuJ4VxNaU8XkDJ3lvAYgxaVO0QwLThhnYo6atxTbEMdgc2UGV22T_227mKpPk8cUwzD6PIbB9FUYOm_HEId8jk4602d_ccgL9PH48L58rlevTy_L-1VtCcNjOQ8UW4MFI8Ctk85h7q1XUrHONYaBaX0LnYIydsqDI0pZTqUy0nMuDF2gm_3ebYpfU_lDb0K2vu_N4OOUtZCSSEF5EV7_E67jlMrTWRMgQgiGRRHhvcimmHPynd6msDHpW2PQO6h6D1UXqHoHVTfFc3VYPLUb7_4cB4r0B-AFcbg</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Novak, Joshua</creator><creator>Katz, Jeffry A</creator><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>Probiotics and prebiotics for gastrointestinal infections</title><author>Novak, Joshua ; Katz, Jeffry A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Epidemiology</topic><topic>Gastrointestinal diseases</topic><topic>Health promotion</topic><topic>Infectious diseases</topic><topic>Medical treatment</topic><topic>Prevention</topic><topic>Probiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Novak, Joshua</creatorcontrib><creatorcontrib>Katz, Jeffry A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Current infectious disease reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Novak, Joshua</au><au>Katz, Jeffry A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Probiotics and prebiotics for gastrointestinal infections</atitle><jtitle>Current infectious disease reports</jtitle><addtitle>Curr Infect Dis Rep</addtitle><date>2006-03</date><risdate>2006</risdate><volume>8</volume><issue>2</issue><spage>103</spage><epage>109</epage><pages>103-109</pages><issn>1523-3847</issn><eissn>1534-3146</eissn><abstract>There is growing interest in and knowledge about the potential health-promoting benefits of both probiotics and prebiotics. Multiple mechanisms of action for the beneficial effect of probiotics and prebiotics have been postulated, including prevention of pathogenic bacteria growth, production of antimicrobial agents, stimulation of mucosal barrier function, and altering immunoregulation. Clinical trials support the efficacy of probiotics in the treatment of acute infectious diarrhea, the prevention of antibiotic associated diarrhea, and the prevention of recurrent Clostridium difficile infection. Although some data support the potential benefit of probiotic therapy in traveler's diarrhea, diverticular disease, and Helicobacter pylori, the strength of this evidence is limited. This paper will review the recent literature relevant to the mechanism of action and utility of probiotics and prebiotics in the treatment of gastrointestinal infections.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16524546</pmid><doi>10.1007/s11908-006-0005-9</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1523-3847
ispartof Current infectious disease reports, 2006-03, Vol.8 (2), p.103-109
issn 1523-3847
1534-3146
language eng
recordid cdi_proquest_miscellaneous_67727635
source Springer Link
subjects Antimicrobial agents
Bacterial infections
Epidemiology
Gastrointestinal diseases
Health promotion
Infectious diseases
Medical treatment
Prevention
Probiotics
title Probiotics and prebiotics for gastrointestinal infections
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A26%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Probiotics%20and%20prebiotics%20for%20gastrointestinal%20infections&rft.jtitle=Current%20infectious%20disease%20reports&rft.au=Novak,%20Joshua&rft.date=2006-03&rft.volume=8&rft.issue=2&rft.spage=103&rft.epage=109&rft.pages=103-109&rft.issn=1523-3847&rft.eissn=1534-3146&rft_id=info:doi/10.1007/s11908-006-0005-9&rft_dat=%3Cproquest_cross%3E67727635%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c241t-38031ca164205cd7dd15ece8784fd9a40abeb0f8015ed8e0d288c5378a7e556a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=202666416&rft_id=info:pmid/16524546&rfr_iscdi=true